Brief: Biocartis Launches Idylla SARS-CoV-2/Flu/RSV Panel

Biocartis NV

02/09/2021 06:06

Sept 2 (Reuters) - Biocartis Group NV  BCART.BR :
    * REG-PRESS NEWS BIOCARTIS GROUP NV: BIOCARTIS LAUNCHES
IDYLLA
SARS-COV-2/FLU/RSV PANEL
    * LAUNCH OF ITS IDYLLA SARS-COV-2/FLU/RSV PANEL (CE-IVD)
    * NEW PANEL IS LAUNCHING AS A CE-IVD AND DETECTS, IN ONE
SINGLE
CARTRIDGE, SARS-COV-2, FLU A/B AND RSV1 NUCLEIC ACIDS, WITH
RESULTS IN APPROX. 90 MINUTES
    * PANEL SHOWED EXCELLENT PERFORMANCE IN CLINICAL PERFORMANCE
STUDY
WITH 98% OVERALL CONCORDANCE COMPARED WITH OTHER CURRENTLY USED
METHODS

Source text for Eikon:  ID:nGNEbz4sBQ 
Further company coverage:  BCART.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))